Medications
FDA adds most severe warning to Pfizer's Tygacil
Regulators are putting their harshest warning on Pfizer's antibiotic Tygacil, saying the drug is associated with an increased risk of death.
Sep 30, 2013
0
0
Page 7 - News tagged with intravenous drugs
Medications
FDA takes action to ease neonatal drug shortage
(AP)—Federal health regulators will allow overseas imports of a critical intravenous drug formula used to nourish premature infants, amid a shortage that has impacted hospitals nationwide.
May 29, 2013
0
0
Medications
FDA: Omontys injection pulled from market
(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis patients, following ...
Feb 26, 2013
0
0
Diseases, Conditions, Syndromes
Hepatitis risk a concern for baby boomers
(Medical Xpress)—Older adults are asking more questions about liver health now that the Centers for Disease Control and Prevention has formally called for baby boomers to get tested for Hepatitis C, says Dr. Luis Balart, ...
Sep 24, 2012
1
0
HIV & AIDS
Russia HIV infections rise 5% in 2011: official
Russia in 2011 saw a rise of five percent in the number of new HIV infections to 62,000 cases amid worrying signs that heterosexuals and women are increasingly at risk, its chief doctor said Monday.
Mar 12, 2012
0
0
Medications
University of Minnesota and start-up to develop antidote to cyanide poisoning
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup ...
Feb 9, 2012
0
0
Medical research
NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB
Investigators at Nationwide Children's have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans.
May 25, 2011
0
0
